Jacobs School of Medicine and Biomedical Sciences researchers are conducting a clinical trial to assess the effectiveness of structured financial incentives in lowering cardiovascular disease (CVD) risk among African Americans facing food insecurity.
As the only physician at an Antarctic research station, Shawn Vainio, MD ’03, was a one-man medical team. He recounted his decades of wilderness medicine experience at a UB Global Health Grand Rounds talk.
A paper published today explains why there needs to be a shift in cannabis policies to a public health approach as opposed to the prevailing, more punitive approach that pushes abstinence instead of public education.
A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.
An initiative led by PhD student and social justice fellowship recipient Rhonda Drewes aims to save lives by registering AEDs, especially in underserved areas.
Updated results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma is treated in newly diagnosed adolescents and adults.
During the DoctHERS Annual Symposium at the Jacobs School of Medicine and Biomedical Sciences, featured speaker Donnica Moore, MD ’86, called upon physicians and medical students alike to be good communicators in an age of medical misinformation.
UB's new Aging and Resilience Research Center on The Brothers of Mercy Wellness Campus in Clarence, N.Y., is dedicated to identifying the factors that contribute to healthy, resilient aging.
Several Jacobs School of Medicine and Biomedical Sciences faculty members were honored by the Medical Society of the County of Erie (MSCE) during its Save a Life! Gala Oct. 10 at the Buffalo Convention Center.
Jennifer A. Surtees, PhD, professor of biochemistry and associate dean of undergraduate education and STEM outreach in the Jacobs School, is principal investigator on a $2.45 million NIH grant funding DNA research and diversity enhancement.